Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

Study Questions:

What are the cardiovascular and renal benefits associated with blood pressure treatment targets of <140/90 mm Hg or <130/80 mm Hg in patients at high cardiovascular risk?